TLDR
- Cathie Wood’s ARK ETFs acquired 169,130 shares of Roblox, valued at $13.7 million, on January 6, 2026.
- ARK divested 19,316 shares of Meta Platforms, worth $12.7 million, across several ETFs.
- Through its robotics ETF, ARK purchased 39,296 shares of Kodiak AI for $409,000.
- ARK decreased its biotech holdings, selling $1.8 million in Guardant Health and $568,000 in Ionis Pharmaceuticals.
- These transactions indicate ARK’s increased investment in gaming and AI companies, alongside reduced exposure to Meta and healthcare stocks.
Cathie Wood’s ARK Invest executed a series of portfolio adjustments on January 6, 2026, notably increasing its stake in Roblox and reducing its holdings in Meta Platforms. These trades highlight a continued strategic focus on gaming and autonomous technology, while decreasing exposure to social media and biotechnology sectors.
ARK acquired 169,130 shares of Roblox Corp, distributed among three of its exchange-traded funds: the ARK Innovation ETF, ARK Next Generation Internet ETF, and ARK Fintech Innovation ETF. The total value of this acquisition amounted to $13.7 million.
This investment in Roblox builds upon ARK’s prior commitments to the gaming platform, demonstrating sustained interest in the company during recent trading periods. The online gaming platform remains a component of ARK’s growth investment strategy.
On the divestment front, ARK reduced its position in Meta Platforms. The firm sold 19,316 shares of Meta across the same three ETFs utilized for the Roblox acquisition. The total value of the Meta share sale reached $12.7 million.
ARK Adds to AI and Robotics Holdings
The sale of Meta shares is consistent with a trend of diminishing ARK’s exposure to the social media company. ARK has been trimming its Meta stake in multiple recent trading sessions, suggesting a potential shift in Wood’s perspective on the stock’s prospects.
Furthermore, ARK expanded its investment in Kodiak AI. The autonomous driving technology firm saw its shares purchased through the ARK Autonomous Technology & Robotics ETF. ARK acquired 39,296 shares of Kodiak AI for an approximate cost of $409,000.
This acquisition of Kodiak AI follows recent accumulation of the stock, as ARK has been steadily increasing its position in the autonomous driving company over several days. These actions underscore Wood’s ongoing interest in the artificial intelligence and robotics sectors.
Healthcare Holdings Face Reductions
ARK also reduced its holdings in two biotechnology companies on Tuesday. The firm sold 17,613 shares of Guardant Health via its ARK Genomic Revolution ETF, with the sale valued at approximately $1.8 million.
Additionally, ARK decreased its stake in Ionis Pharmaceuticals, selling 7,228 shares for roughly $568,000. Both of these sales were exclusively executed through the genomics-focused ETF.
Wall Street analysts currently hold mixed opinions on these stocks. Roblox is rated a Moderate Buy with significant upside potential. Both Kodiak AI and Meta Platforms carry Strong Buy consensus ratings from analysts.
The biotechnology stocks, Guardant Health and Ionis Pharmaceuticals, also hold Strong Buy ratings from analysts. However, their projected upside is comparatively lower than that of the technology stocks. ARK’s trading activities were detailed in the firm’s daily trade filings for January 6, 2026.
